lunes, 14 de enero de 2019

Cystic Fibrosis News Today Weekly Digest


Cystic Fibrosis Weekly Update

Contents:

Alcresta’s Relizorb Given Medicare/Medicaid Billing Code for Easier Claims

Jan 09, 2019 07:00 am | Vijaya Iyer



code to ease insuranceThe Centers for Medicare and Medicaid Services (CMS) has issued a permanent billing code (B4105) to Alcresta Therapeutics’ in-line digestive enzyme cartridge Relizorb, making it easier for insurance payers and potentially more accessible to patients. The code, effective on Jan. 1, should now enable coverage for Relizorb that can be separately reimbursed without any technical […]
The post Alcresta’s Relizorb Given Medicare/Medicaid Billing Code for Easier Claims appeared first on Cystic Fibrosis News Today.
Read More
share on TwitterLike Alcresta’s Relizorb Given Medicare/Medicaid Billing Code for Easier Claims on Facebook

My Trip to Hawaii Symbolizes My Victory Over Death by CF

Jan 08, 2019 09:00 am | Brad Dell



hawaiiA friend sat with me above heaven, a sapphire ocean embracing two lush islands and the greater island beneath our butts — Oahu. On that mountaintop, I rambled about finding meaning in all things. Most transplant patients I’ve met are spiritual in some way, injecting meaning where it doesn’t exist for others. We cultivate gratitude […]
The post My Trip to Hawaii Symbolizes My Victory Over Death by CF appeared first on Cystic Fibrosis News Today.
Read More
share on TwitterLike My Trip to Hawaii Symbolizes My Victory Over Death by CF on Facebook

Vertex and Arbor Biotechnologies Collaborating to Develop Cystic Fibrosis Gene Therapies

Jan 08, 2019 07:00 am | Catarina Silva



Vertex, Arbor partnershipVertex Pharmaceuticals and Arbor Biotechnologies have established a partnership to discover new proteins to advance the development of gene therapies for cystic fibrosis. The companies also plan to develop new genome-editing approaches for four other diseases but haven’t revealed which ones yet. Under the terms of the agreement, Arbor will primarily carry out the laboratory […]
The post Vertex and Arbor Biotechnologies Collaborating to Develop Cystic Fibrosis Gene Therapies appeared first on Cystic Fibrosis News Today.
Read More
share on TwitterLike Vertex and Arbor Biotechnologies Collaborating to Develop Cystic Fibrosis Gene Therapies on Facebook
 

Recent News

Empowering Children by Educating Them About Their CF
Claire’s Place Foundation Grants to Help CF Families Reaches $1 Million Milestone
Vertex to Request Review of Orkambi, Symkevi Plus Kalydeco for Public Funding in Scotland
Top 10 Cystic Fibrosis Stories of 2018
Using Food as Medicine to Manage CF: A Nutritionist’s View

No hay comentarios:

Publicar un comentario